The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
PROVIDENCE — Kin Southern Table & Bar, a popular restaurant in downtown, has permanently closed. The 50-seat restaurant was located on the ground floor of the Biltmore Garage on Washington ...
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a leading biotechnology company specializing in cystic fibrosis (CF) treatments, has been making significant strides in expanding its therapeutic ...
Providence Restaurant Weeks are set for Jan ... The second-course choices include a Stuffie, a cup of Rhode Island or Clam Chowder or Mussels in White Wine. Finish with a third course of choosing ...
Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.72% to $416.96 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.21 ...
PROVIDENCE, R.I. (WPRI) — The Rhode Island State Police have fired two troopers who posted a video on social media of 21-year-old Alex Montesino getting hit and killed by a car on I-95 in October.
It usually doesn't matter if you buy a given stock immediately or two weeks later. Sure, the stock could move up or down but typically not enough to matter all that much. However, there are ...
The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $416.96, reflecting a -1.72% shift from the previouse trading day's closing. The stock's performance was behind ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results